This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information
Choose your country
Coming soon!
New blot technology for efficient Lyme disease diagnostics.
The miniaturised immunoblots in microplate format allow high-throughput analysis with minimal hands-on time. ELISA and EUROMicroblots can be processed in parallel on the same automated instrument. The EUROMicroblots are reliably evaluated using the new Microwell Imager and the proven EUROLineScan Software.
The latest clinical guideline by the KDIGO highlights the importance of the detection of anti-PLA2R antibodies for the diagnosis of primary membranous nephropathy. The KDIGO also recommends the quantitative measurement of autoantibodies to evaluate therapy response and disease prognosis.
websiteTrendsetting software for intelligently connected IIFT diagnostics
Via EUROLabPolaris, indirect immunofluorescence data can be transferred securely to several locations enabling central evaluation within the software to make full use of expert knowledge.
According to in silico analysis, the new SARS-CoV-2 variant, called Omicron, is expected to be reliably detected by our EURORealTime SARS-CoV-2 and EURORealTime SARS-CoV-2/Influenza A/B tests systems. This also applies to the virus variants Alpha, Beta, Gamma, Delta, Lambda and Mu. At this early stage it is not yet possible to make a statement about the possible effects of the Omicron variant on the performance of the EUROIMMUN antibody test systems or the interferon-gamma release assay Quan-T-Cell SARS-CoV-2.
moreBy using the EURORealTime SARS-CoV-2/Influenza A/B for parallel detection and identification of SARS-CoV-2 and influenza virus types A and B it is possible to keep an eye on the spread of not only COVID-19 but also of the upcoming flu in an efficient and resource-saving way.
websiteNow with CE mark! The Quan-T-Cell SARS-CoV-2 in combination with the Quan-T-Cell ELISA allows determination of the activity of SARS-CoV-2-reactive T cells and supports the evaluation of the cellular immune response to SARS-CoV-2 after infection or vaccination.
WebsiteWe have more than 30 years of expertise in developing and producing high-quality solutions for IFA diagnostics and providing suitable options for all lab sizes − always a perfect match for your demands.
Watch VideoOur new brochure explains the most important pitfalls in CSF-based dementia diagnostics. Based on concrete examples from representative studies, the effects of different laboratory practices on the measured beta-amyloid concentrations are demonstrated.
Please request a free PDF copy of your brochure here.
moreNew video course (by MEDILOGIN) on mycology for dermatologists available. 13 interesting lessons introduce you to the world of dermatophytes, yeasts and moulds, from the basics to state-of-the-art diagnostics.
WebsiteThe new surrogate virus neutralisation test for the determination of neutralising antibodies supplements our CE-marked QuantiVac ELISA and the Quan-T-Cell to support the evaluation of the immune response to SARS-CoV-2 after infection or vaccination with a S1/RBD-based vaccine.
websiteEUROPattern Microscope Live is an ultrafast and fully automated immunofluorescence system. The enormous speed of the image processing is complemented by the high comfort of the user software EUROLabOffice 4.0 for evaluation of the immunofluorescence images directly on the computer screen.
moreNew ELISA for quantitative detection of antibodies against viral S1 antigen. The ELISA is the first antibody test to allow quantification of antibody concentration in standardised units (BAU/ml). This can be a valuable support for assessment of individual immune responses to SARS-CoV-2 after infection or vaccination.
websiteMoulds of the genus Aspergillus are present in the air and soil, but also in biological waste and contaminated foods. Within the genus, which encompasses more than 300 species, some may lead to infections in humans, given the respective predisposition. Here, Aspergillus fumigatus plays an especially important role.
moreFree public antibody testing in Böblingen: EUROIMMUN provides tests for pilot project in Southern Germany
EUROLabPolaris – Trendsetting software for intelligently connected IIFT diagnostics
EUROIMMUN and Homed-IQ offer Corporate COVID-19 Antibody Testing Program
Exotic emerging diseases
The PerkinElmer Global Innovation Awards 2021 ceremony
New guideline recognises anti-PLA2R as a significant biomarker for membranous nephropathy
T cells: Important building blocks of immune protection against SARS-CoV-2
The flu season is getting started
New partnership: IDS and EUROIMMUN
Impact of SARS-CoV-2 variants on antibody tests
EUROIMMUN Launches SARS-CoV-2 NeutraLISA Assay to Determine the Neutralizing Capacity of Anti-SARS-CoV-2 Antibodies
Oncgnostics and EUROIMMUN Announce Collaboration to Distribute Cervical Cancer Test GynTect
EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics
EUROIMMUN Launches SARS-CoV-2 Test System to Detect T-Cell Response
Novel ELISA for Detection of SARS-CoV-2 Antigen in Acutely Infected COVID-19-Patients
New PCR test to differentiate between COVID-19 and flu
Novel ELISA for Quantification of Antibodies against S1 Protein of SARS-CoV-2
INOCHEM becomes part of EUROIMMUN family
EURORealTime SARS-CoV-2 approved by the FDA via an Emergency Use Authorization
SARS-CoV-2 Testing from EUROIMMUN
FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies
EUROIMMUN now offers a complete test package for direct detection of the new coronavirus and antibodies against SARS-CoV-2
Tests for detection of antibodies against SARS-CoV-2 now available
A new German law on mandatory measles vaccination
Fast and reliable detection of dermatomycosis pathogens
The Immunoblot PreQ System
EUROIMMUN Calprotectin ELISA
EUROArray HPV: More certainty in the early diagnosis of cervical cancer
Anti-MERS-CoV ELISA and IIFT: First commercial tests worldwide for the determination of antibodies against MERS coronavirus in humans and camels.
Reliable diagnosis of dengue virus infections in all disease stages
Anti-Borrelia EUROLINE-RN-AT-adv: highest specificity for borreliosis diagnostics through OspC advanced
Designer antigens – customised for laboratory diagnostics
Recombinant Cell IFT (RC-IIFT) – the quickest way to bring new research parameters into the diagnostic laboratory
EUROPattern: Software for image capturing and interpretation of IIFT patterns in autoimmune diagnostics
New products for Chlamydia diagnostics
Anti-NMDA receptor encephalitis: Recombinant immunofluorescence test for determination of antibodies against glutamate receptors
EUROIMMUN 25-OH Vitamin D ELISA: a reliable, convenient test